Aethlon Medical, Inc.
AEMDNASDAQHealthcare● Active
$2.03
+$0.12(+6.28%)
Market Cap$1545400
P/E Ratio—
52W High$29.6
52W Low$1.36
Aethlon Medical, Inc. (AEMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AEMD · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 12, 2026EPS Actual
-$2.45
Est. -$2.01 · -21.9%
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 12, 2026
After Market Close
▼ Miss EPS
AEMD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 10, 2026 | -$2.46 | — | — | — | — | — |
| ▼ Q1 FY2026 | Feb 12, 2026 | -$2.01 | -$2.45 | -21.9% | — | — | — |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$1.70 | -$3.74 | -120.0% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$6.80 | -$8.50 | -25.0% | — | — | — |
| ▼ Q2 FY2025 | Jun 26, 2025 | -$0.98 | -$7.28 | -642.9% | $0.00B | — | — |
| ▲ Q1 FY2025 | Feb 12, 2025 | -$0.22 | -$0.13 | +40.9% | — | — | — |
| — Q4 FY2024 | Nov 13, 2024 | -$0.20 | -$0.20 | +0.0% | — | — | — |
| ▲ Q3 FY2024 | Aug 14, 2024 | -$0.44 | -$0.34 | +22.7% | — | — | — |
Q2 FY2026
Jun 10, 2026
EPS Actual
—
EPS Est.
-$2.46
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
-$2.45
EPS Est.
-$2.01
EPS Surpr.
-21.9%
Revenue
—
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$3.74
EPS Est.
-$1.70
EPS Surpr.
-120.0%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$8.50
EPS Est.
-$6.80
EPS Surpr.
-25.0%
Revenue
—
Q2 FY2025
Jun 26, 2025Miss
EPS Actual
-$7.28
EPS Est.
-$0.98
EPS Surpr.
-642.9%
Revenue
$0.00B
Q1 FY2025
Feb 12, 2025Beat
EPS Actual
-$0.13
EPS Est.
-$0.22
EPS Surpr.
+40.9%
Revenue
—
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.20
EPS Est.
-$0.20
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2024
Aug 14, 2024Beat
EPS Actual
-$0.34
EPS Est.
-$0.44
EPS Surpr.
+22.7%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $-0.46 | $-0.46 | $-0.46 | 1 |
| Q4 FY2026 | $-0.48 | $-0.48 | $-0.48 | 1 |
| Q3 FY2026 | $-0.71 | $-0.71 | $-0.71 | 1 |
| Q2 FY2026 | $-0.75 | $-0.75 | $-0.75 | 1 |
| Q1 FY2026 | $-2.17 | $-2.17 | $-2.15 | 2 |
| Q4 FY2025 | $-2.75 | $-2.75 | $-2.75 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 12, 2026 | -21.9% | $2.09 | $1.98 | -5.26% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -120.0% | $4.34 | $4.20 | -3.23% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -25.0% | $12.60 | $12.30 | -2.38% |
| ▼ Q2 FY2025 | Jun 26, 2025 | -642.9% | $15.70 | $19.40 | +23.57% |
| ▲ Q1 FY2025 | Feb 12, 2025 | +40.9% | $54.50 | $53.40 | -2.02% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +0.0% | $31.50 | $32.50 | +3.17% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +22.7% | $26.60 | $30.80 | +15.79% |
| ▲ Q2 FY2024 | Jun 27, 2024 | +22.9% | $46.80 | $46.30 | -1.07% |
Q1 FY2026-5.26%
Report Date
Feb 12, 2026
EPS Beat/Miss
-21.9%
Price Before
$2.09
Price After
$1.98
Q4 FY2025-3.23%
Report Date
Nov 12, 2025
EPS Beat/Miss
-120.0%
Price Before
$4.34
Price After
$4.20
Q3 FY2025-2.38%
Report Date
Aug 13, 2025
EPS Beat/Miss
-25.0%
Price Before
$12.60
Price After
$12.30
Q2 FY2025+23.57%
Report Date
Jun 26, 2025
EPS Beat/Miss
-642.9%
Price Before
$15.70
Price After
$19.40
Q1 FY2025-2.02%
Report Date
Feb 12, 2025
EPS Beat/Miss
+40.9%
Price Before
$54.50
Price After
$53.40
Q4 FY2024+3.17%
Report Date
Nov 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$31.50
Price After
$32.50
Q3 FY2024+15.79%
Report Date
Aug 14, 2024
EPS Beat/Miss
+22.7%
Price Before
$26.60
Price After
$30.80
Q2 FY2024-1.07%
Report Date
Jun 27, 2024
EPS Beat/Miss
+22.9%
Price Before
$46.80
Price After
$46.30
Avg Beat Reaction+3.97%
Avg Miss Reaction+3.17%
Beat Rate4 / 8 quarters
Largest Move+23.57% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AEMD ends December
Aethlon Medical, Inc. (AEMD) most recently reported earnings on February 12, 2026 for Q1 FY2026, posting EPS of $-2.45 — missing the analyst consensus of $-2.01 by -21.9%. The next AEMD earnings date is expected around September 1, 2026.
Each quarter, investors track AEMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AEMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AEMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AEMD earnings · 5 questionsAethlon Medical, Inc.'s next earnings report is expected around September 1, 2026. AEMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AEMD historically reports after market close (AMC).
AEMD earnings datewhen is AEMD earningsAEMD next earnings datewhen does AEMD report earningsAEMD earnings calendar
▸ Source: FMP · Aethlon Medical, Inc. SEC filings · US GAAP · Aethlon Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026